CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI ...

New MRI technology aims to advance neuroimaging and biomarker research CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a ...

GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with Freelium, aimed at boosting efficiency, advancing precision diagnostics and ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare’s innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic gadolinium-based MRI ...

GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology. Unveiled at the ...

GE Healthcare unveiled SIGNA Pioneer, a new 510(k) pending 3.0T magnetic resonance imaging (MRI) system that embodies the exploration and expansion of modern medical imaging. Leveraging novel ...